Inter Pharma Share Price

Equities

IP

TH9474010005

Pharmaceuticals

End-of-day quote Thailand S.E. 03:30:00 30/04/2024 am IST 5-day change 1st Jan Change
9.9 THB -.--% Intraday chart for Inter Pharma +4.21% +10.00%

Financials

Sales 2024 * 2.26B 61.24M 5.11B Sales 2025 * 2.71B 73.28M 6.12B Capitalization 3.69B 99.8M 8.33B
Net income 2024 * 177M 4.79M 400M Net income 2025 * 209M 5.66M 472M EV / Sales 2024 * 1.63 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 1.36 x
P/E ratio 2024 *
23 x
P/E ratio 2025 *
17.7 x
Employees -
Yield 2024 *
2.53%
Yield 2025 *
2.83%
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Inter Pharma Public Company Limited Approves Dividend for the Year 2023, Payable on May 24, 2024 CI
Inter Pharma Public Company Limited (SET:IP) agreed to acquire 70% stake in Metta Medtech Company Limited from Sittisak Phanitpotchaman for THB 130 million. CI
Inter Pharma Public Company Limited Proposes Dividend for the Year 2023, Payable on May 24, 2024 CI
Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Inter Pharma Public Company Limited Announces Resignation of Mrs. Nattarin Polpuech as Director, Member of Risk Management Committee and Member of the Executive Committee CI
Inter Pharma Public Company Limited Announces CFO Changes CI
Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Inter Pharma Public Company Limited Approves Dividend for the Year 2022, Payable on May 26, 2023 CI
Inter Pharma Public Company Limited Approves Board Changes CI
Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Inter Pharma Public Company Limited Announces Resignation of Terdkiat Prommool as Director CI
Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
More news
1 week+4.21%
Current month+4.21%
1 month+4.21%
3 months+7.61%
6 months+3.66%
Current year+10.00%
More quotes
1 week
9.65
Extreme 9.65
10.30
1 month
9.45
Extreme 9.45
10.30
Current year
7.80
Extreme 7.8
10.30
1 year
7.80
Extreme 7.8
13.50
3 years
7.80
Extreme 7.8
24.30
5 years
2.63
Extreme 2.6286
24.60
10 years
2.63
Extreme 2.6286
24.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 01/14/01
Chief Operating Officer 49 14/17/14
Director/Board Member 54 20/22/20
Members of the board TitleAgeSince
Director/Board Member 54 08/21/08
Chairman 70 17/19/17
Chief Operating Officer 49 14/17/14
More insiders
Date Price Change Volume
30/24/30 9.9 -.--% 202,591
29/24/29 9.9 -0.50% 271,030
26/24/26 9.95 -0.50% 356,536
25/24/25 10 +0.50% 426,474
24/24/24 9.95 +1.53% 298,047

End-of-day quote Thailand S.E., April 30, 2024

More quotes
Interpharma Public Company Limited is a Thailand-based company that develops, researches and distributes healthcare products and beauty initiatives for human beings, and healthcare products for animals. The Company provides wellness and anti-aging products, aesthetic innovation products, companion animal health products and livestock products. Its products include PREBO, YUUU toothpaste, multivitamin, Probac 7, Probac 10, Beta Glucan Plus, Pure Krill Oil, Astacurmin, YUUU cleansing mousse, Perfectha Complement, Perfectha Derm, Perfectha Deep, Perfectha Subskin and Uderma.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
9.9 THB
Average target price
17 THB
Spread / Average Target
+71.72%
Consensus